nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—pancreatic cancer—germ cell cancer	0.518	1	CtDrD
Tamoxifen—ABCB11—Vinblastine—germ cell cancer	0.0259	0.0823	CbGbCtD
Tamoxifen—CYP2A6—Ifosfamide—germ cell cancer	0.0251	0.0797	CbGbCtD
Tamoxifen—ABCG2—Dactinomycin—germ cell cancer	0.0197	0.0624	CbGbCtD
Tamoxifen—CYP3A7—Ifosfamide—germ cell cancer	0.0171	0.0545	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0171	0.0545	CbGbCtD
Tamoxifen—CYP2B6—Ifosfamide—germ cell cancer	0.0163	0.0519	CbGbCtD
Tamoxifen—ABCC2—Vinblastine—germ cell cancer	0.0136	0.0433	CbGbCtD
Tamoxifen—CYP3A5—Ifosfamide—germ cell cancer	0.0129	0.0409	CbGbCtD
Tamoxifen—ABCC2—Cisplatin—germ cell cancer	0.0125	0.0397	CbGbCtD
Tamoxifen—CYP2C8—Ifosfamide—germ cell cancer	0.0124	0.0393	CbGbCtD
Tamoxifen—ABCC2—Etoposide—germ cell cancer	0.0123	0.039	CbGbCtD
Tamoxifen—ABCG2—Cisplatin—germ cell cancer	0.0113	0.0359	CbGbCtD
Tamoxifen—ABCG2—Etoposide—germ cell cancer	0.0111	0.0352	CbGbCtD
Tamoxifen—CYP2C19—Ifosfamide—germ cell cancer	0.0104	0.033	CbGbCtD
Tamoxifen—CYP2C9—Ifosfamide—germ cell cancer	0.00863	0.0274	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—germ cell cancer	0.00811	0.0258	CbGbCtD
Tamoxifen—CYP2B6—Cisplatin—germ cell cancer	0.00794	0.0252	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—germ cell cancer	0.00791	0.0251	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—germ cell cancer	0.00733	0.0233	CbGbCtD
Tamoxifen—ABCB1—Dactinomycin—germ cell cancer	0.00709	0.0225	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—germ cell cancer	0.00615	0.0195	CbGbCtD
Tamoxifen—CYP2C8—Etoposide—germ cell cancer	0.00591	0.0188	CbGbCtD
Tamoxifen—CYP3A4—Ifosfamide—germ cell cancer	0.00502	0.0159	CbGbCtD
Tamoxifen—CYP1A2—Etoposide—germ cell cancer	0.00457	0.0145	CbGbCtD
Tamoxifen—ABCB1—Vinblastine—germ cell cancer	0.00444	0.0141	CbGbCtD
Tamoxifen—CYP2C9—Cisplatin—germ cell cancer	0.0042	0.0133	CbGbCtD
Tamoxifen—CYP2D6—Vinblastine—germ cell cancer	0.00418	0.0133	CbGbCtD
Tamoxifen—ABCB1—Cisplatin—germ cell cancer	0.00407	0.0129	CbGbCtD
Tamoxifen—ABCB1—Etoposide—germ cell cancer	0.004	0.0127	CbGbCtD
Tamoxifen—CYP3A4—Vinblastine—germ cell cancer	0.00266	0.00845	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—germ cell cancer	0.00264	0.0084	CbGbCtD
Tamoxifen—ESRRA—Preimplantation Embryo—DPPA3—germ cell cancer	0.0025	0.0646	CbGpPWpGaD
Tamoxifen—CYP3A4—Etoposide—germ cell cancer	0.0024	0.00761	CbGbCtD
Tamoxifen—ESR2—seminiferous tubule of testis—germ cell cancer	0.00219	0.0434	CbGeAlD
Tamoxifen—ESR2—Validated nuclear estrogen receptor beta network—NR0B1—germ cell cancer	0.00215	0.0557	CbGpPWpGaD
Tamoxifen—CYP2C9—cardial valve—germ cell cancer	0.00197	0.0389	CbGeAlD
Tamoxifen—ESRRA—Preimplantation Embryo—ZFP42—germ cell cancer	0.00189	0.0489	CbGpPWpGaD
Tamoxifen—CYP19A1—seminiferous tubule of testis—germ cell cancer	0.00173	0.0342	CbGeAlD
Tamoxifen—ESRRA—Nuclear Receptors—NR0B1—germ cell cancer	0.00161	0.0416	CbGpPWpGaD
Tamoxifen—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00149	0.0386	CbGpPWpGaD
Tamoxifen—SULT1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.00134	0.0346	CbGpPWpGaD
Tamoxifen—ESRRA—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00127	0.0329	CbGpPWpGaD
Tamoxifen—FMO3—urine—germ cell cancer	0.00124	0.0245	CbGeAlD
Tamoxifen—FMO1—Metapathway biotransformation—NAT9—germ cell cancer	0.00111	0.0287	CbGpPWpGaD
Tamoxifen—ESR2—Nuclear Receptors—NR0B1—germ cell cancer	0.00102	0.0265	CbGpPWpGaD
Tamoxifen—ESRRA—Preimplantation Embryo—NANOG—germ cell cancer	0.000994	0.0257	CbGpPWpGaD
Tamoxifen—ESRRA—Preimplantation Embryo—DNMT3L—germ cell cancer	0.000994	0.0257	CbGpPWpGaD
Tamoxifen—ESRRA—Preimplantation Embryo—POU5F1—germ cell cancer	0.000957	0.0247	CbGpPWpGaD
Tamoxifen—SULT1A1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000896	0.0232	CbGpPWpGaD
Tamoxifen—ESR2—Ovarian Infertility Genes—INHA—germ cell cancer	0.000865	0.0224	CbGpPWpGaD
Tamoxifen—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000856	0.0221	CbGpPWpGaD
Tamoxifen—ESR2—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000808	0.0209	CbGpPWpGaD
Tamoxifen—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000806	0.0208	CbGpPWpGaD
Tamoxifen—FMO3—Metapathway biotransformation—NAT9—germ cell cancer	0.000793	0.0205	CbGpPWpGaD
Tamoxifen—SULT1A1—neck—germ cell cancer	0.000781	0.0154	CbGeAlD
Tamoxifen—ESRRA—Preimplantation Embryo—KLF4—germ cell cancer	0.000753	0.0195	CbGpPWpGaD
Tamoxifen—SULT1A1—trigeminal ganglion—germ cell cancer	0.000674	0.0133	CbGeAlD
Tamoxifen—ESR2—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.000674	0.0174	CbGpPWpGaD
Tamoxifen—UGT1A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000665	0.0172	CbGpPWpGaD
Tamoxifen—CYP2C19—urine—germ cell cancer	0.000547	0.0108	CbGeAlD
Tamoxifen—ESRRA—Preimplantation Embryo—SOX2—germ cell cancer	0.000531	0.0137	CbGpPWpGaD
Tamoxifen—EBP—uterus—germ cell cancer	0.00053	0.0105	CbGeAlD
Tamoxifen—SULT1A1—telencephalon—germ cell cancer	0.00053	0.0105	CbGeAlD
Tamoxifen—ESR1—Nuclear Receptors—NR0B1—germ cell cancer	0.000516	0.0133	CbGpPWpGaD
Tamoxifen—CYP19A1—Ovarian Infertility Genes—INHA—germ cell cancer	0.000487	0.0126	CbGpPWpGaD
Tamoxifen—EBPL—adrenal gland—germ cell cancer	0.000485	0.00959	CbGeAlD
Tamoxifen—DHCR7—trigeminal ganglion—germ cell cancer	0.00048	0.00949	CbGeAlD
Tamoxifen—FMO1—trigeminal ganglion—germ cell cancer	0.00048	0.00949	CbGeAlD
Tamoxifen—ESRRA—trigeminal ganglion—germ cell cancer	0.000472	0.00934	CbGeAlD
Tamoxifen—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000463	0.012	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000461	0.0119	CbGpPWpGaD
Tamoxifen—EBPL—female gonad—germ cell cancer	0.000452	0.00894	CbGeAlD
Tamoxifen—CYP1A2—urine—germ cell cancer	0.000447	0.00884	CbGeAlD
Tamoxifen—SULT1A1—pituitary gland—germ cell cancer	0.000431	0.00853	CbGeAlD
Tamoxifen—CYP2C9—urine—germ cell cancer	0.000424	0.00839	CbGeAlD
Tamoxifen—EBPL—endocrine gland—germ cell cancer	0.00042	0.00832	CbGeAlD
Tamoxifen—EBPL—head—germ cell cancer	0.000415	0.00821	CbGeAlD
Tamoxifen—DHCR7—retina—germ cell cancer	0.000409	0.0081	CbGeAlD
Tamoxifen—ESR1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000408	0.0105	CbGpPWpGaD
Tamoxifen—EBP—endocrine gland—germ cell cancer	0.000403	0.00797	CbGeAlD
Tamoxifen—CYP2E1—urine—germ cell cancer	0.000402	0.00795	CbGeAlD
Tamoxifen—EBPL—testis—germ cell cancer	0.000401	0.00793	CbGeAlD
Tamoxifen—SULT1A1—adrenal gland—germ cell cancer	0.000385	0.00762	CbGeAlD
Tamoxifen—CES1—neck—germ cell cancer	0.000379	0.0075	CbGeAlD
Tamoxifen—DHCR7—telencephalon—germ cell cancer	0.000377	0.00745	CbGeAlD
Tamoxifen—SULT1A1—spinal cord—germ cell cancer	0.000371	0.00734	CbGeAlD
Tamoxifen—EBPL—cerebellum—germ cell cancer	0.00037	0.00733	CbGeAlD
Tamoxifen—CYP19A1—Metapathway biotransformation—NAT9—germ cell cancer	0.00037	0.00957	CbGpPWpGaD
Tamoxifen—DHCR7—skin of body—germ cell cancer	0.000359	0.00711	CbGeAlD
Tamoxifen—SULT1A1—female gonad—germ cell cancer	0.000359	0.00711	CbGeAlD
Tamoxifen—FMO3—eye—germ cell cancer	0.000357	0.00706	CbGeAlD
Tamoxifen—CYP1A1—skin epidermis—germ cell cancer	0.000357	0.00706	CbGeAlD
Tamoxifen—CYP1B1—Metapathway biotransformation—NAT9—germ cell cancer	0.000356	0.00921	CbGpPWpGaD
Tamoxifen—ESRRA—decidua—germ cell cancer	0.000351	0.00695	CbGeAlD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000346	0.00896	CbGpPWpGaD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.00034	0.00879	CbGpPWpGaD
Tamoxifen—SULT1A1—endocrine gland—germ cell cancer	0.000334	0.00661	CbGeAlD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000333	0.00862	CbGpPWpGaD
Tamoxifen—SULT1A1—head—germ cell cancer	0.00033	0.00652	CbGeAlD
Tamoxifen—ESR2—neck—germ cell cancer	0.000328	0.00649	CbGeAlD
Tamoxifen—CYP3A4—urine—germ cell cancer	0.000324	0.0064	CbGeAlD
Tamoxifen—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.000321	0.00831	CbGpPWpGaD
Tamoxifen—SULT1A1—testis—germ cell cancer	0.000319	0.0063	CbGeAlD
Tamoxifen—CYP2D6—urine—germ cell cancer	0.000318	0.0063	CbGeAlD
Tamoxifen—DHCR7—gonad—germ cell cancer	0.000314	0.00622	CbGeAlD
Tamoxifen—ESR1—blood vessel—germ cell cancer	0.000314	0.00622	CbGeAlD
Tamoxifen—ESRRA—uterus—germ cell cancer	0.000307	0.00608	CbGeAlD
Tamoxifen—DHCR7—pituitary gland—germ cell cancer	0.000307	0.00607	CbGeAlD
Tamoxifen—FMO1—pituitary gland—germ cell cancer	0.000307	0.00607	CbGeAlD
Tamoxifen—ESRRA—pituitary gland—germ cell cancer	0.000302	0.00597	CbGeAlD
Tamoxifen—EBPL—brain—germ cell cancer	0.000301	0.00595	CbGeAlD
Tamoxifen—DHCR7—medulla oblongata—germ cell cancer	0.000296	0.00585	CbGeAlD
Tamoxifen—SULT1A1—cerebellum—germ cell cancer	0.000294	0.00582	CbGeAlD
Tamoxifen—UGT1A4—endocrine gland—germ cell cancer	0.000291	0.00577	CbGeAlD
Tamoxifen—ESRRA—medulla oblongata—germ cell cancer	0.000291	0.00576	CbGeAlD
Tamoxifen—EBPL—lymph node—germ cell cancer	0.000291	0.00575	CbGeAlD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000287	0.00741	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000276	0.00714	CbGpPWpGaD
Tamoxifen—DHCR7—adrenal gland—germ cell cancer	0.000274	0.00542	CbGeAlD
Tamoxifen—FMO1—adrenal gland—germ cell cancer	0.000274	0.00542	CbGeAlD
Tamoxifen—DHCR7—midbrain—germ cell cancer	0.000271	0.00535	CbGeAlD
Tamoxifen—ESRRA—adrenal gland—germ cell cancer	0.00027	0.00534	CbGeAlD
Tamoxifen—ESRRA—midbrain—germ cell cancer	0.000266	0.00527	CbGeAlD
Tamoxifen—FMO3—pituitary gland—germ cell cancer	0.000265	0.00524	CbGeAlD
Tamoxifen—DHCR7—bone marrow—germ cell cancer	0.000265	0.00524	CbGeAlD
Tamoxifen—DHCR7—spinal cord—germ cell cancer	0.000264	0.00522	CbGeAlD
Tamoxifen—ESRRA—bone marrow—germ cell cancer	0.000261	0.00516	CbGeAlD
Tamoxifen—ESRRA—spinal cord—germ cell cancer	0.00026	0.00514	CbGeAlD
Tamoxifen—CES1—NRF2 pathway—SLC2A3—germ cell cancer	0.000257	0.00665	CbGpPWpGaD
Tamoxifen—DHCR7—female gonad—germ cell cancer	0.000255	0.00505	CbGeAlD
Tamoxifen—FMO1—female gonad—germ cell cancer	0.000255	0.00505	CbGeAlD
Tamoxifen—ESRRA—female gonad—germ cell cancer	0.000252	0.00498	CbGeAlD
Tamoxifen—ESR2—brainstem—germ cell cancer	0.000251	0.00496	CbGeAlD
Tamoxifen—SULT1A1—brain—germ cell cancer	0.000239	0.00473	CbGeAlD
Tamoxifen—FMO1—endocrine gland—germ cell cancer	0.000238	0.0047	CbGeAlD
Tamoxifen—DHCR7—endocrine gland—germ cell cancer	0.000238	0.0047	CbGeAlD
Tamoxifen—CYP2B6—Metapathway biotransformation—NAT9—germ cell cancer	0.000238	0.00614	CbGpPWpGaD
Tamoxifen—FMO3—adrenal gland—germ cell cancer	0.000237	0.00468	CbGeAlD
Tamoxifen—DHCR7—head—germ cell cancer	0.000235	0.00464	CbGeAlD
Tamoxifen—FMO1—head—germ cell cancer	0.000235	0.00464	CbGeAlD
Tamoxifen—ESRRA—endocrine gland—germ cell cancer	0.000234	0.00463	CbGeAlD
Tamoxifen—CYP2E1—Metapathway biotransformation—NAT9—germ cell cancer	0.000233	0.00602	CbGpPWpGaD
Tamoxifen—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000232	0.00601	CbGpPWpGaD
Tamoxifen—SULT1A1—lymph node—germ cell cancer	0.000231	0.00457	CbGeAlD
Tamoxifen—ESRRA—head—germ cell cancer	0.000231	0.00457	CbGeAlD
Tamoxifen—DHCR7—testis—germ cell cancer	0.000227	0.00448	CbGeAlD
Tamoxifen—ESR1—neck—germ cell cancer	0.000225	0.00445	CbGeAlD
Tamoxifen—ESRRA—testis—germ cell cancer	0.000223	0.00441	CbGeAlD
Tamoxifen—ESR2—telencephalon—germ cell cancer	0.000223	0.0044	CbGeAlD
Tamoxifen—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.00022	0.00569	CbGpPWpGaD
Tamoxifen—SIGMAR1—trigeminal ganglion—germ cell cancer	0.00022	0.00434	CbGeAlD
Tamoxifen—ESRRA—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000219	0.00568	CbGpPWpGaD
Tamoxifen—CYP1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000219	0.00567	CbGpPWpGaD
Tamoxifen—DHCR7—cerebellum—germ cell cancer	0.000209	0.00414	CbGeAlD
Tamoxifen—UGT1A4—NRF2 pathway—SLC2A3—germ cell cancer	0.000209	0.0054	CbGpPWpGaD
Tamoxifen—ABCB11—endocrine gland—germ cell cancer	0.000208	0.00411	CbGeAlD
Tamoxifen—ESRRA—cerebellum—germ cell cancer	0.000206	0.00408	CbGeAlD
Tamoxifen—FMO3—endocrine gland—germ cell cancer	0.000205	0.00406	CbGeAlD
Tamoxifen—CYP3A7—endocrine gland—germ cell cancer	0.000203	0.00402	CbGeAlD
Tamoxifen—FMO3—head—germ cell cancer	0.000203	0.00401	CbGeAlD
Tamoxifen—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000201	0.0052	CbGpPWpGaD
Tamoxifen—ABCB11—testis—germ cell cancer	0.000198	0.00392	CbGeAlD
Tamoxifen—FMO3—testis—germ cell cancer	0.000196	0.00387	CbGeAlD
Tamoxifen—SIGMAR1—eye—germ cell cancer	0.000189	0.00374	CbGeAlD
Tamoxifen—ESR1—embryo—germ cell cancer	0.000187	0.00371	CbGeAlD
Tamoxifen—CES1—adrenal gland—germ cell cancer	0.000187	0.0037	CbGeAlD
Tamoxifen—ESR2—gonad—germ cell cancer	0.000186	0.00367	CbGeAlD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000185	0.00478	CbGpPWpGaD
Tamoxifen—ESR2—uterus—germ cell cancer	0.000185	0.00365	CbGeAlD
Tamoxifen—ESR2—pituitary gland—germ cell cancer	0.000181	0.00358	CbGeAlD
Tamoxifen—CYP1B1—eye—germ cell cancer	0.00018	0.00356	CbGeAlD
Tamoxifen—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.000179	0.00464	CbGpPWpGaD
Tamoxifen—CES1—female gonad—germ cell cancer	0.000174	0.00345	CbGeAlD
Tamoxifen—SIGMAR1—telencephalon—germ cell cancer	0.000172	0.00341	CbGeAlD
Tamoxifen—ESR1—brainstem—germ cell cancer	0.000172	0.0034	CbGeAlD
Tamoxifen—DHCR7—brain—germ cell cancer	0.00017	0.00336	CbGeAlD
Tamoxifen—FMO1—brain—germ cell cancer	0.00017	0.00336	CbGeAlD
Tamoxifen—ESRRA—brain—germ cell cancer	0.000167	0.00331	CbGeAlD
Tamoxifen—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000165	0.00427	CbGpPWpGaD
Tamoxifen—DHCR7—lymph node—germ cell cancer	0.000164	0.00325	CbGeAlD
Tamoxifen—FMO1—lymph node—germ cell cancer	0.000164	0.00325	CbGeAlD
Tamoxifen—CYP1B1—telencephalon—germ cell cancer	0.000164	0.00324	CbGeAlD
Tamoxifen—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000164	0.00423	CbGpPWpGaD
Tamoxifen—SIGMAR1—decidua—germ cell cancer	0.000163	0.00323	CbGeAlD
Tamoxifen—CES1—endocrine gland—germ cell cancer	0.000162	0.00321	CbGeAlD
Tamoxifen—ESR2—adrenal gland—germ cell cancer	0.000162	0.0032	CbGeAlD
Tamoxifen—ESRRA—lymph node—germ cell cancer	0.000162	0.0032	CbGeAlD
Tamoxifen—CES1—head—germ cell cancer	0.00016	0.00317	CbGeAlD
Tamoxifen—Erythema multiforme—Dactinomycin—germ cell cancer	0.000157	0.00201	CcSEcCtD
Tamoxifen—CYP1B1—skin of body—germ cell cancer	0.000156	0.0031	CbGeAlD
Tamoxifen—Cramp muscle—Etoposide—germ cell cancer	0.000156	0.002	CcSEcCtD
Tamoxifen—CYP2E1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000156	0.00404	CbGpPWpGaD
Tamoxifen—ABCG2—trigeminal ganglion—germ cell cancer	0.000155	0.00308	CbGeAlD
Tamoxifen—CYP1B1—decidua—germ cell cancer	0.000155	0.00307	CbGeAlD
Tamoxifen—Pancytopenia—Cisplatin—germ cell cancer	0.000155	0.00199	CcSEcCtD
Tamoxifen—Erythema—Bleomycin—germ cell cancer	0.000155	0.00199	CcSEcCtD
Tamoxifen—CES1—testis—germ cell cancer	0.000155	0.00306	CbGeAlD
Tamoxifen—Discomfort—Vinblastine—germ cell cancer	0.000154	0.00198	CcSEcCtD
Tamoxifen—Flushing—Dactinomycin—germ cell cancer	0.000154	0.00198	CcSEcCtD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000153	0.00396	CbGpPWpGaD
Tamoxifen—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000153	0.00196	CcSEcCtD
Tamoxifen—Haemoglobin—Ifosfamide—germ cell cancer	0.000153	0.00196	CcSEcCtD
Tamoxifen—ESR1—telencephalon—germ cell cancer	0.000152	0.00302	CbGeAlD
Tamoxifen—Hepatitis—Ifosfamide—germ cell cancer	0.000152	0.00195	CcSEcCtD
Tamoxifen—Haemorrhage—Ifosfamide—germ cell cancer	0.000152	0.00195	CcSEcCtD
Tamoxifen—ESR2—female gonad—germ cell cancer	0.000151	0.00299	CbGeAlD
Tamoxifen—Dysphagia—Etoposide—germ cell cancer	0.00015	0.00192	CcSEcCtD
Tamoxifen—Inflammation—Methotrexate—germ cell cancer	0.000147	0.00189	CcSEcCtD
Tamoxifen—FMO3—brain—germ cell cancer	0.000147	0.00291	CbGeAlD
Tamoxifen—Vasculitis—Methotrexate—germ cell cancer	0.000147	0.00188	CcSEcCtD
Tamoxifen—Alopecia—Dactinomycin—germ cell cancer	0.000146	0.00188	CcSEcCtD
Tamoxifen—CYP19A1—gonad—germ cell cancer	0.000146	0.0029	CbGeAlD
Tamoxifen—Thrombocytopenia—Vinblastine—germ cell cancer	0.000146	0.00188	CcSEcCtD
Tamoxifen—Visual impairment—Ifosfamide—germ cell cancer	0.000146	0.00188	CcSEcCtD
Tamoxifen—CYP19A1—uterus—germ cell cancer	0.000145	0.00288	CbGeAlD
Tamoxifen—ESR1—decidua—germ cell cancer	0.000144	0.00286	CbGeAlD
Tamoxifen—Erythema—Dactinomycin—germ cell cancer	0.000144	0.00185	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Cisplatin—germ cell cancer	0.000144	0.00185	CcSEcCtD
Tamoxifen—Erythema multiforme—Ifosfamide—germ cell cancer	0.000144	0.00184	CcSEcCtD
Tamoxifen—Pulmonary embolism—Methotrexate—germ cell cancer	0.000143	0.00184	CcSEcCtD
Tamoxifen—Vaginal inflammation—Methotrexate—germ cell cancer	0.000143	0.00184	CcSEcCtD
Tamoxifen—SIGMAR1—uterus—germ cell cancer	0.000143	0.00283	CbGeAlD
Tamoxifen—Anaemia—Bleomycin—germ cell cancer	0.000143	0.00184	CcSEcCtD
Tamoxifen—Myocardial infarction—Cisplatin—germ cell cancer	0.000143	0.00184	CcSEcCtD
Tamoxifen—Anorexia—Vinblastine—germ cell cancer	0.000142	0.00183	CcSEcCtD
Tamoxifen—Pancytopenia—Etoposide—germ cell cancer	0.000142	0.00183	CcSEcCtD
Tamoxifen—FMO3—lymph node—germ cell cancer	0.000142	0.00281	CbGeAlD
Tamoxifen—Flushing—Ifosfamide—germ cell cancer	0.000141	0.00181	CcSEcCtD
Tamoxifen—SIGMAR1—pituitary gland—germ cell cancer	0.00014	0.00278	CbGeAlD
Tamoxifen—ESR2—endocrine gland—germ cell cancer	0.00014	0.00278	CbGeAlD
Tamoxifen—Neutropenia—Etoposide—germ cell cancer	0.00014	0.0018	CcSEcCtD
Tamoxifen—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.00014	0.00362	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00014	0.00361	CbGpPWpGaD
Tamoxifen—ESR2—head—germ cell cancer	0.000139	0.00274	CbGeAlD
Tamoxifen—Leukopenia—Bleomycin—germ cell cancer	0.000138	0.00178	CcSEcCtD
Tamoxifen—CYP1B1—gonad—germ cell cancer	0.000137	0.00271	CbGeAlD
Tamoxifen—Skin exfoliation—Methotrexate—germ cell cancer	0.000137	0.00175	CcSEcCtD
Tamoxifen—CYP1B1—uterus—germ cell cancer	0.000136	0.00269	CbGeAlD
Tamoxifen—Arrhythmia—Ifosfamide—germ cell cancer	0.000136	0.00174	CcSEcCtD
Tamoxifen—SIGMAR1—medulla oblongata—germ cell cancer	0.000135	0.00268	CbGeAlD
Tamoxifen—Vaginal infection—Methotrexate—germ cell cancer	0.000135	0.00173	CcSEcCtD
Tamoxifen—Cough—Bleomycin—germ cell cancer	0.000135	0.00173	CcSEcCtD
Tamoxifen—Pneumonia—Etoposide—germ cell cancer	0.000134	0.00173	CcSEcCtD
Tamoxifen—Paraesthesia—Vinblastine—germ cell cancer	0.000134	0.00172	CcSEcCtD
Tamoxifen—Alopecia—Ifosfamide—germ cell cancer	0.000134	0.00172	CcSEcCtD
Tamoxifen—ESR2—testis—germ cell cancer	0.000134	0.00265	CbGeAlD
Tamoxifen—CYP1B1—pituitary gland—germ cell cancer	0.000134	0.00264	CbGeAlD
Tamoxifen—Anaemia—Dactinomycin—germ cell cancer	0.000133	0.00171	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000132	0.0017	CcSEcCtD
Tamoxifen—Erythema—Ifosfamide—germ cell cancer	0.000132	0.0017	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Etoposide—germ cell cancer	0.000132	0.00169	CcSEcCtD
Tamoxifen—Chest pain—Bleomycin—germ cell cancer	0.000132	0.00169	CcSEcCtD
Tamoxifen—Myalgia—Bleomycin—germ cell cancer	0.000132	0.00169	CcSEcCtD
Tamoxifen—Myocardial infarction—Etoposide—germ cell cancer	0.000131	0.00168	CcSEcCtD
Tamoxifen—Discomfort—Bleomycin—germ cell cancer	0.00013	0.00167	CcSEcCtD
Tamoxifen—Decreased appetite—Vinblastine—germ cell cancer	0.00013	0.00167	CcSEcCtD
Tamoxifen—Neoplasm—Methotrexate—germ cell cancer	0.000129	0.00166	CcSEcCtD
Tamoxifen—Leukopenia—Dactinomycin—germ cell cancer	0.000129	0.00166	CcSEcCtD
Tamoxifen—Pain—Vinblastine—germ cell cancer	0.000128	0.00164	CcSEcCtD
Tamoxifen—Constipation—Vinblastine—germ cell cancer	0.000128	0.00164	CcSEcCtD
Tamoxifen—CYP19A1—adrenal gland—germ cell cancer	0.000128	0.00252	CbGeAlD
Tamoxifen—ESR1—gonad—germ cell cancer	0.000127	0.00252	CbGeAlD
Tamoxifen—ESR1—uterus—germ cell cancer	0.000126	0.0025	CbGeAlD
Tamoxifen—Oedema—Bleomycin—germ cell cancer	0.000126	0.00162	CcSEcCtD
Tamoxifen—Visual impairment—Cisplatin—germ cell cancer	0.000126	0.00162	CcSEcCtD
Tamoxifen—SIGMAR1—adrenal gland—germ cell cancer	0.000125	0.00248	CbGeAlD
Tamoxifen—Infection—Bleomycin—germ cell cancer	0.000125	0.00161	CcSEcCtD
Tamoxifen—CYP2A6—cerebellum—germ cell cancer	0.000124	0.00246	CbGeAlD
Tamoxifen—Sepsis—Methotrexate—germ cell cancer	0.000124	0.00159	CcSEcCtD
Tamoxifen—ESR1—pituitary gland—germ cell cancer	0.000124	0.00246	CbGeAlD
Tamoxifen—ABCB1—blood vessel—germ cell cancer	0.000124	0.00245	CbGeAlD
Tamoxifen—SIGMAR1—midbrain—germ cell cancer	0.000124	0.00245	CbGeAlD
Tamoxifen—ESR2—cerebellum—germ cell cancer	0.000124	0.00245	CbGeAlD
Tamoxifen—Thrombocytopenia—Bleomycin—germ cell cancer	0.000124	0.00159	CcSEcCtD
Tamoxifen—CES1—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000123	0.00318	CbGpPWpGaD
Tamoxifen—Myalgia—Dactinomycin—germ cell cancer	0.000123	0.00158	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000122	0.00157	CcSEcCtD
Tamoxifen—Anaemia—Ifosfamide—germ cell cancer	0.000122	0.00157	CcSEcCtD
Tamoxifen—ABCG2—telencephalon—germ cell cancer	0.000122	0.00242	CbGeAlD
Tamoxifen—ABCC2—adrenal gland—germ cell cancer	0.000122	0.00241	CbGeAlD
Tamoxifen—Flushing—Cisplatin—germ cell cancer	0.000122	0.00156	CcSEcCtD
Tamoxifen—Discomfort—Dactinomycin—germ cell cancer	0.000121	0.00156	CcSEcCtD
Tamoxifen—SIGMAR1—bone marrow—germ cell cancer	0.000121	0.0024	CbGeAlD
Tamoxifen—SIGMAR1—spinal cord—germ cell cancer	0.000121	0.00239	CbGeAlD
Tamoxifen—Angioedema—Ifosfamide—germ cell cancer	0.000121	0.00155	CcSEcCtD
Tamoxifen—Anorexia—Bleomycin—germ cell cancer	0.00012	0.00155	CcSEcCtD
Tamoxifen—Hypoaesthesia—Etoposide—germ cell cancer	0.000119	0.00153	CcSEcCtD
Tamoxifen—CYP1B1—adrenal gland—germ cell cancer	0.000119	0.00236	CbGeAlD
Tamoxifen—CYP19A1—female gonad—germ cell cancer	0.000119	0.00235	CbGeAlD
Tamoxifen—Leukopenia—Ifosfamide—germ cell cancer	0.000118	0.00152	CcSEcCtD
Tamoxifen—Abdominal pain—Vinblastine—germ cell cancer	0.000118	0.00152	CcSEcCtD
Tamoxifen—Oedema—Dactinomycin—germ cell cancer	0.000118	0.00151	CcSEcCtD
Tamoxifen—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	0.000117	0.00303	CbGpPWpGaD
Tamoxifen—Infection—Dactinomycin—germ cell cancer	0.000117	0.0015	CcSEcCtD
Tamoxifen—Arrhythmia—Cisplatin—germ cell cancer	0.000117	0.0015	CcSEcCtD
Tamoxifen—SIGMAR1—female gonad—germ cell cancer	0.000117	0.00231	CbGeAlD
Tamoxifen—CES1—brain—germ cell cancer	0.000116	0.00229	CbGeAlD
Tamoxifen—ABCG2—decidua—germ cell cancer	0.000116	0.00229	CbGeAlD
Tamoxifen—Alopecia—Cisplatin—germ cell cancer	0.000116	0.00149	CcSEcCtD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000116	0.00299	CbGpPWpGaD
Tamoxifen—Hepatic failure—Methotrexate—germ cell cancer	0.000116	0.00148	CcSEcCtD
Tamoxifen—Cough—Ifosfamide—germ cell cancer	0.000115	0.00148	CcSEcCtD
Tamoxifen—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000115	0.00148	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000115	0.00148	CcSEcCtD
Tamoxifen—Hypertension—Ifosfamide—germ cell cancer	0.000114	0.00147	CcSEcCtD
Tamoxifen—Erythema—Cisplatin—germ cell cancer	0.000114	0.00146	CcSEcCtD
Tamoxifen—Erythema multiforme—Etoposide—germ cell cancer	0.000113	0.00146	CcSEcCtD
Tamoxifen—Paraesthesia—Bleomycin—germ cell cancer	0.000113	0.00146	CcSEcCtD
Tamoxifen—Dyspnoea—Bleomycin—germ cell cancer	0.000113	0.00145	CcSEcCtD
Tamoxifen—Chest pain—Ifosfamide—germ cell cancer	0.000113	0.00145	CcSEcCtD
Tamoxifen—Myalgia—Ifosfamide—germ cell cancer	0.000113	0.00145	CcSEcCtD
Tamoxifen—Arthralgia—Ifosfamide—germ cell cancer	0.000113	0.00145	CcSEcCtD
Tamoxifen—Anorexia—Dactinomycin—germ cell cancer	0.000112	0.00144	CcSEcCtD
Tamoxifen—CES1—lymph node—germ cell cancer	0.000112	0.00222	CbGeAlD
Tamoxifen—Flushing—Etoposide—germ cell cancer	0.000111	0.00143	CcSEcCtD
Tamoxifen—CYP1B1—female gonad—germ cell cancer	0.000111	0.0022	CbGeAlD
Tamoxifen—Discomfort—Ifosfamide—germ cell cancer	0.000111	0.00143	CcSEcCtD
Tamoxifen—ESR1—adrenal gland—germ cell cancer	0.000111	0.00219	CbGeAlD
Tamoxifen—CYP19A1—endocrine gland—germ cell cancer	0.000111	0.00219	CbGeAlD
Tamoxifen—CYP1A1—skin of body—germ cell cancer	0.000111	0.00219	CbGeAlD
Tamoxifen—Hypersensitivity—Vinblastine—germ cell cancer	0.00011	0.00141	CcSEcCtD
Tamoxifen—Decreased appetite—Bleomycin—germ cell cancer	0.00011	0.00141	CcSEcCtD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.00011	0.00284	CbGpPWpGaD
Tamoxifen—Visual disturbance—Methotrexate—germ cell cancer	0.00011	0.00141	CcSEcCtD
Tamoxifen—Muscle spasms—Cisplatin—germ cell cancer	0.00011	0.00141	CcSEcCtD
Tamoxifen—CYP19A1—head—germ cell cancer	0.000109	0.00216	CbGeAlD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000109	0.00282	CbGpPWpGaD
Tamoxifen—Pain—Bleomycin—germ cell cancer	0.000108	0.00139	CcSEcCtD
Tamoxifen—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000108	0.00279	CbGpPWpGaD
Tamoxifen—Oedema—Ifosfamide—germ cell cancer	0.000108	0.00139	CcSEcCtD
Tamoxifen—CYP2B6—skin of body—germ cell cancer	0.000107	0.00213	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000107	0.00138	CcSEcCtD
Tamoxifen—Asthenia—Vinblastine—germ cell cancer	0.000107	0.00138	CcSEcCtD
Tamoxifen—Infection—Ifosfamide—germ cell cancer	0.000107	0.00138	CcSEcCtD
Tamoxifen—Alopecia—Etoposide—germ cell cancer	0.000106	0.00136	CcSEcCtD
Tamoxifen—CYP2E1—telencephalon—germ cell cancer	0.000106	0.00209	CbGeAlD
Tamoxifen—ESRRA—Gene Expression—NR0B1—germ cell cancer	0.000106	0.00273	CbGpPWpGaD
Tamoxifen—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000106	0.00136	CcSEcCtD
Tamoxifen—ABCC2—endocrine gland—germ cell cancer	0.000106	0.00209	CbGeAlD
Tamoxifen—CYP19A1—testis—germ cell cancer	0.000106	0.00209	CbGeAlD
Tamoxifen—Anaemia—Cisplatin—germ cell cancer	0.000105	0.00135	CcSEcCtD
Tamoxifen—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000104	0.00134	CcSEcCtD
Tamoxifen—Osteoarthritis—Methotrexate—germ cell cancer	0.000104	0.00133	CcSEcCtD
Tamoxifen—SIGMAR1—testis—germ cell cancer	0.000104	0.00205	CbGeAlD
Tamoxifen—CYP1B1—endocrine gland—germ cell cancer	0.000103	0.00205	CbGeAlD
Tamoxifen—ESR1—female gonad—germ cell cancer	0.000103	0.00205	CbGeAlD
Tamoxifen—Anorexia—Ifosfamide—germ cell cancer	0.000103	0.00132	CcSEcCtD
Tamoxifen—Decreased appetite—Dactinomycin—germ cell cancer	0.000102	0.00131	CcSEcCtD
Tamoxifen—Diarrhoea—Vinblastine—germ cell cancer	0.000102	0.00131	CcSEcCtD
Tamoxifen—Dysgeusia—Etoposide—germ cell cancer	0.000102	0.00131	CcSEcCtD
Tamoxifen—CYP2C8—pituitary gland—germ cell cancer	0.000102	0.00202	CbGeAlD
Tamoxifen—CYP1B1—head—germ cell cancer	0.000102	0.00202	CbGeAlD
Tamoxifen—Leukopenia—Cisplatin—germ cell cancer	0.000102	0.00131	CcSEcCtD
Tamoxifen—Fatigue—Dactinomycin—germ cell cancer	0.000102	0.0013	CcSEcCtD
Tamoxifen—ABCG2—uterus—germ cell cancer	0.000101	0.002	CbGeAlD
Tamoxifen—Back pain—Etoposide—germ cell cancer	0.000101	0.0013	CcSEcCtD
Tamoxifen—CYP2A6—brain—germ cell cancer	0.000101	0.002	CbGeAlD
Tamoxifen—ABCC2—testis—germ cell cancer	0.000101	0.00199	CbGeAlD
Tamoxifen—Pain—Dactinomycin—germ cell cancer	0.000101	0.00129	CcSEcCtD
Tamoxifen—ESR2—brain—germ cell cancer	0.0001	0.00199	CbGeAlD
Tamoxifen—Muscle spasms—Etoposide—germ cell cancer	0.0001	0.00129	CcSEcCtD
Tamoxifen—Urticaria—Bleomycin—germ cell cancer	0.0001	0.00129	CcSEcCtD
Tamoxifen—ABCG2—pituitary gland—germ cell cancer	9.94e-05	0.00197	CbGeAlD
Tamoxifen—Dizziness—Vinblastine—germ cell cancer	9.88e-05	0.00127	CcSEcCtD
Tamoxifen—CYP1B1—testis—germ cell cancer	9.86e-05	0.00195	CbGeAlD
Tamoxifen—Mood swings—Methotrexate—germ cell cancer	9.84e-05	0.00126	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	9.83e-05	0.00126	CcSEcCtD
Tamoxifen—ESR2—lymph node—germ cell cancer	9.7e-05	0.00192	CbGeAlD
Tamoxifen—Myalgia—Cisplatin—germ cell cancer	9.7e-05	0.00125	CcSEcCtD
Tamoxifen—Paraesthesia—Ifosfamide—germ cell cancer	9.69e-05	0.00124	CcSEcCtD
Tamoxifen—Anxiety—Cisplatin—germ cell cancer	9.67e-05	0.00124	CcSEcCtD
Tamoxifen—Anaemia—Etoposide—germ cell cancer	9.65e-05	0.00124	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dactinomycin—germ cell cancer	9.63e-05	0.00124	CcSEcCtD
Tamoxifen—Dyspnoea—Ifosfamide—germ cell cancer	9.62e-05	0.00124	CcSEcCtD
Tamoxifen—ESR1—endocrine gland—germ cell cancer	9.61e-05	0.0019	CbGeAlD
Tamoxifen—CYP1A1—uterus—germ cell cancer	9.61e-05	0.0019	CbGeAlD
Tamoxifen—ABCG2—medulla oblongata—germ cell cancer	9.59e-05	0.0019	CbGeAlD
Tamoxifen—Liver function test abnormal—Methotrexate—germ cell cancer	9.59e-05	0.00123	CcSEcCtD
Tamoxifen—Discomfort—Cisplatin—germ cell cancer	9.59e-05	0.00123	CcSEcCtD
Tamoxifen—SIGMAR1—cerebellum—germ cell cancer	9.58e-05	0.00189	CbGeAlD
Tamoxifen—Vomiting—Vinblastine—germ cell cancer	9.5e-05	0.00122	CcSEcCtD
Tamoxifen—ESR1—head—germ cell cancer	9.49e-05	0.00188	CbGeAlD
Tamoxifen—CYP2D6—brainstem—germ cell cancer	9.43e-05	0.00187	CbGeAlD
Tamoxifen—CYP2B6—gonad—germ cell cancer	9.4e-05	0.00186	CbGeAlD
Tamoxifen—Decreased appetite—Ifosfamide—germ cell cancer	9.38e-05	0.0012	CcSEcCtD
Tamoxifen—Headache—Vinblastine—germ cell cancer	9.36e-05	0.0012	CcSEcCtD
Tamoxifen—Leukopenia—Etoposide—germ cell cancer	9.35e-05	0.0012	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Ifosfamide—germ cell cancer	9.31e-05	0.0012	CcSEcCtD
Tamoxifen—Abdominal pain—Dactinomycin—germ cell cancer	9.31e-05	0.0012	CcSEcCtD
Tamoxifen—Fatigue—Ifosfamide—germ cell cancer	9.3e-05	0.00119	CcSEcCtD
Tamoxifen—Oedema—Cisplatin—germ cell cancer	9.3e-05	0.00119	CcSEcCtD
Tamoxifen—Hypersensitivity—Bleomycin—germ cell cancer	9.3e-05	0.00119	CcSEcCtD
Tamoxifen—CYP2A6—NRF2 pathway—SLC2A3—germ cell cancer	9.24e-05	0.00239	CbGpPWpGaD
Tamoxifen—Infection—Cisplatin—germ cell cancer	9.24e-05	0.00119	CcSEcCtD
Tamoxifen—Pain—Ifosfamide—germ cell cancer	9.23e-05	0.00118	CcSEcCtD
Tamoxifen—Constipation—Ifosfamide—germ cell cancer	9.23e-05	0.00118	CcSEcCtD
Tamoxifen—ESR1—testis—germ cell cancer	9.17e-05	0.00181	CbGeAlD
Tamoxifen—ESRRA—Gene Expression—DNMT3L—germ cell cancer	9.16e-05	0.00237	CbGpPWpGaD
Tamoxifen—Cough—Etoposide—germ cell cancer	9.11e-05	0.00117	CcSEcCtD
Tamoxifen—CYP1B1—cerebellum—germ cell cancer	9.11e-05	0.0018	CbGeAlD
Tamoxifen—Thrombocytopenia—Cisplatin—germ cell cancer	9.11e-05	0.00117	CcSEcCtD
Tamoxifen—CYP2C19—endocrine gland—germ cell cancer	9.07e-05	0.0018	CbGeAlD
Tamoxifen—Asthenia—Bleomycin—germ cell cancer	9.06e-05	0.00116	CcSEcCtD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—AVP—germ cell cancer	9.02e-05	0.00233	CbGpPWpGaD
Tamoxifen—Hypertension—Etoposide—germ cell cancer	9.01e-05	0.00116	CcSEcCtD
Tamoxifen—Hyperhidrosis—Cisplatin—germ cell cancer	8.99e-05	0.00115	CcSEcCtD
Tamoxifen—Pruritus—Bleomycin—germ cell cancer	8.93e-05	0.00115	CcSEcCtD
Tamoxifen—Chest pain—Etoposide—germ cell cancer	8.89e-05	0.00114	CcSEcCtD
Tamoxifen—ABCG2—adrenal gland—germ cell cancer	8.88e-05	0.00176	CbGeAlD
Tamoxifen—Nausea—Vinblastine—germ cell cancer	8.88e-05	0.00114	CcSEcCtD
Tamoxifen—Anorexia—Cisplatin—germ cell cancer	8.87e-05	0.00114	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Ifosfamide—germ cell cancer	8.82e-05	0.00113	CcSEcCtD
Tamoxifen—Pancreatitis—Methotrexate—germ cell cancer	8.8e-05	0.00113	CcSEcCtD
Tamoxifen—Discomfort—Etoposide—germ cell cancer	8.78e-05	0.00113	CcSEcCtD
Tamoxifen—ABCG2—midbrain—germ cell cancer	8.77e-05	0.00173	CbGeAlD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.76e-05	0.00227	CbGpPWpGaD
Tamoxifen—Hypersensitivity—Dactinomycin—germ cell cancer	8.67e-05	0.00111	CcSEcCtD
Tamoxifen—Abdominal discomfort—Methotrexate—germ cell cancer	8.6e-05	0.00111	CcSEcCtD
Tamoxifen—ABCG2—bone marrow—germ cell cancer	8.59e-05	0.0017	CbGeAlD
Tamoxifen—Urticaria—Ifosfamide—germ cell cancer	8.57e-05	0.0011	CcSEcCtD
Tamoxifen—ABCG2—spinal cord—germ cell cancer	8.55e-05	0.00169	CbGeAlD
Tamoxifen—Abdominal pain—Ifosfamide—germ cell cancer	8.53e-05	0.0011	CcSEcCtD
Tamoxifen—Pancytopenia—Methotrexate—germ cell cancer	8.52e-05	0.00109	CcSEcCtD
Tamoxifen—ESRRA—Gene Expression—RARS—germ cell cancer	8.52e-05	0.0022	CbGpPWpGaD
Tamoxifen—Musculoskeletal discomfort—Cisplatin—germ cell cancer	8.47e-05	0.00109	CcSEcCtD
Tamoxifen—ESR1—cerebellum—germ cell cancer	8.47e-05	0.00168	CbGeAlD
Tamoxifen—Infection—Etoposide—germ cell cancer	8.47e-05	0.00109	CcSEcCtD
Tamoxifen—Asthenia—Dactinomycin—germ cell cancer	8.45e-05	0.00108	CcSEcCtD
Tamoxifen—Neutropenia—Methotrexate—germ cell cancer	8.39e-05	0.00108	CcSEcCtD
Tamoxifen—CYP2D6—telencephalon—germ cell cancer	8.37e-05	0.00166	CbGeAlD
Tamoxifen—Paraesthesia—Cisplatin—germ cell cancer	8.35e-05	0.00107	CcSEcCtD
Tamoxifen—Thrombocytopenia—Etoposide—germ cell cancer	8.34e-05	0.00107	CcSEcCtD
Tamoxifen—CYP2E1—medulla oblongata—germ cell cancer	8.31e-05	0.00164	CbGeAlD
Tamoxifen—Dyspnoea—Cisplatin—germ cell cancer	8.29e-05	0.00106	CcSEcCtD
Tamoxifen—ABCG2—female gonad—germ cell cancer	8.28e-05	0.00164	CbGeAlD
Tamoxifen—Erectile dysfunction—Methotrexate—germ cell cancer	8.27e-05	0.00106	CcSEcCtD
Tamoxifen—Hyperhidrosis—Etoposide—germ cell cancer	8.24e-05	0.00106	CcSEcCtD
Tamoxifen—CYP2B6—adrenal gland—germ cell cancer	8.19e-05	0.00162	CbGeAlD
Tamoxifen—Anorexia—Etoposide—germ cell cancer	8.12e-05	0.00104	CcSEcCtD
Tamoxifen—Decreased appetite—Cisplatin—germ cell cancer	8.09e-05	0.00104	CcSEcCtD
Tamoxifen—Diarrhoea—Dactinomycin—germ cell cancer	8.06e-05	0.00103	CcSEcCtD
Tamoxifen—Pneumonia—Methotrexate—germ cell cancer	8.05e-05	0.00103	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Cisplatin—germ cell cancer	8.03e-05	0.00103	CcSEcCtD
Tamoxifen—Vomiting—Bleomycin—germ cell cancer	8.03e-05	0.00103	CcSEcCtD
Tamoxifen—Depression—Methotrexate—germ cell cancer	7.98e-05	0.00102	CcSEcCtD
Tamoxifen—Rash—Bleomycin—germ cell cancer	7.96e-05	0.00102	CcSEcCtD
Tamoxifen—Pain—Cisplatin—germ cell cancer	7.95e-05	0.00102	CcSEcCtD
Tamoxifen—Dermatitis—Bleomycin—germ cell cancer	7.95e-05	0.00102	CcSEcCtD
Tamoxifen—Hypersensitivity—Ifosfamide—germ cell cancer	7.95e-05	0.00102	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	7.93e-05	0.00102	CcSEcCtD
Tamoxifen—CES1—E2F transcription factor network—MYC—germ cell cancer	7.93e-05	0.00205	CbGpPWpGaD
Tamoxifen—ESR2—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	7.92e-05	0.00205	CbGpPWpGaD
Tamoxifen—CYP2C8—endocrine gland—germ cell cancer	7.92e-05	0.00157	CbGeAlD
Tamoxifen—CYP19A1—brain—germ cell cancer	7.91e-05	0.00157	CbGeAlD
Tamoxifen—CYP1A1—female gonad—germ cell cancer	7.86e-05	0.00156	CbGeAlD
Tamoxifen—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	7.85e-05	0.00203	CbGpPWpGaD
Tamoxifen—SIGMAR1—brain—germ cell cancer	7.78e-05	0.00154	CbGeAlD
Tamoxifen—Asthenia—Ifosfamide—germ cell cancer	7.74e-05	0.000994	CcSEcCtD
Tamoxifen—CYP2E1—adrenal gland—germ cell cancer	7.69e-05	0.00152	CbGeAlD
Tamoxifen—CYP3A5—female gonad—germ cell cancer	7.69e-05	0.00152	CbGeAlD
Tamoxifen—Sweating—Methotrexate—germ cell cancer	7.67e-05	0.000985	CcSEcCtD
Tamoxifen—ABCB1—trigeminal ganglion—germ cell cancer	7.67e-05	0.00152	CbGeAlD
Tamoxifen—Paraesthesia—Etoposide—germ cell cancer	7.65e-05	0.000983	CcSEcCtD
Tamoxifen—CYP19A1—lymph node—germ cell cancer	7.65e-05	0.00151	CbGeAlD
Tamoxifen—Pruritus—Ifosfamide—germ cell cancer	7.63e-05	0.00098	CcSEcCtD
Tamoxifen—Dyspnoea—Etoposide—germ cell cancer	7.6e-05	0.000976	CcSEcCtD
Tamoxifen—CYP2C8—testis—germ cell cancer	7.55e-05	0.00149	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—germ cell cancer	7.52e-05	0.00149	CbGeAlD
Tamoxifen—Nausea—Bleomycin—germ cell cancer	7.5e-05	0.000963	CcSEcCtD
Tamoxifen—Vomiting—Dactinomycin—germ cell cancer	7.49e-05	0.000961	CcSEcCtD
Tamoxifen—Rash—Dactinomycin—germ cell cancer	7.42e-05	0.000953	CcSEcCtD
Tamoxifen—CYP1A2—endocrine gland—germ cell cancer	7.41e-05	0.00147	CbGeAlD
Tamoxifen—Decreased appetite—Etoposide—germ cell cancer	7.41e-05	0.000951	CcSEcCtD
Tamoxifen—CYP2E1—spinal cord—germ cell cancer	7.41e-05	0.00147	CbGeAlD
Tamoxifen—ABCB1—embryo—germ cell cancer	7.4e-05	0.00146	CbGeAlD
Tamoxifen—CYP1B1—brain—germ cell cancer	7.4e-05	0.00146	CbGeAlD
Tamoxifen—Diarrhoea—Ifosfamide—germ cell cancer	7.38e-05	0.000948	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Etoposide—germ cell cancer	7.36e-05	0.000945	CcSEcCtD
Tamoxifen—Fatigue—Etoposide—germ cell cancer	7.35e-05	0.000943	CcSEcCtD
Tamoxifen—ABCG2—testis—germ cell cancer	7.34e-05	0.00145	CbGeAlD
Tamoxifen—CYP1A1—endocrine gland—germ cell cancer	7.31e-05	0.00145	CbGeAlD
Tamoxifen—ABCC2—lymph node—germ cell cancer	7.3e-05	0.00144	CbGeAlD
Tamoxifen—Constipation—Etoposide—germ cell cancer	7.29e-05	0.000936	CcSEcCtD
Tamoxifen—Pain—Etoposide—germ cell cancer	7.29e-05	0.000936	CcSEcCtD
Tamoxifen—Haemoglobin—Methotrexate—germ cell cancer	7.22e-05	0.000927	CcSEcCtD
Tamoxifen—CYP1A1—head—germ cell cancer	7.22e-05	0.00143	CbGeAlD
Tamoxifen—Hepatitis—Methotrexate—germ cell cancer	7.18e-05	0.000923	CcSEcCtD
Tamoxifen—Haemorrhage—Methotrexate—germ cell cancer	7.18e-05	0.000923	CcSEcCtD
Tamoxifen—CYP1B1—lymph node—germ cell cancer	7.15e-05	0.00141	CbGeAlD
Tamoxifen—CYP3A5—endocrine gland—germ cell cancer	7.15e-05	0.00141	CbGeAlD
Tamoxifen—Dizziness—Ifosfamide—germ cell cancer	7.13e-05	0.000916	CcSEcCtD
Tamoxifen—Pharyngitis—Methotrexate—germ cell cancer	7.13e-05	0.000916	CcSEcCtD
Tamoxifen—CYP2B6—endocrine gland—germ cell cancer	7.1e-05	0.00141	CbGeAlD
Tamoxifen—ESR2—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	7.07e-05	0.00183	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—NR0B1—germ cell cancer	7.04e-05	0.00182	CbGpPWpGaD
Tamoxifen—CYP2C9—endocrine gland—germ cell cancer	7.04e-05	0.00139	CbGeAlD
Tamoxifen—CYP2B6—head—germ cell cancer	7.01e-05	0.00139	CbGeAlD
Tamoxifen—Nausea—Dactinomycin—germ cell cancer	6.99e-05	0.000898	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Etoposide—germ cell cancer	6.97e-05	0.000895	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—germ cell cancer	6.92e-05	0.000889	CcSEcCtD
Tamoxifen—ESR1—brain—germ cell cancer	6.88e-05	0.00136	CbGeAlD
Tamoxifen—Vomiting—Ifosfamide—germ cell cancer	6.86e-05	0.000881	CcSEcCtD
Tamoxifen—Hypersensitivity—Cisplatin—germ cell cancer	6.85e-05	0.00088	CcSEcCtD
Tamoxifen—Rash—Ifosfamide—germ cell cancer	6.8e-05	0.000874	CcSEcCtD
Tamoxifen—Dermatitis—Ifosfamide—germ cell cancer	6.8e-05	0.000873	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—germ cell cancer	6.79e-05	0.000872	CcSEcCtD
Tamoxifen—ABCG2—cerebellum—germ cell cancer	6.78e-05	0.00134	CbGeAlD
Tamoxifen—CYP2B6—testis—germ cell cancer	6.78e-05	0.00134	CbGeAlD
Tamoxifen—Urticaria—Etoposide—germ cell cancer	6.77e-05	0.000869	CcSEcCtD
Tamoxifen—Abdominal pain—Etoposide—germ cell cancer	6.74e-05	0.000865	CcSEcCtD
Tamoxifen—ESR2—Gene Expression—NR0B1—germ cell cancer	6.72e-05	0.00174	CbGpPWpGaD
Tamoxifen—Asthenia—Cisplatin—germ cell cancer	6.67e-05	0.000857	CcSEcCtD
Tamoxifen—CYP2E1—endocrine gland—germ cell cancer	6.67e-05	0.00132	CbGeAlD
Tamoxifen—ESR1—lymph node—germ cell cancer	6.65e-05	0.00131	CbGeAlD
Tamoxifen—CYP2E1—head—germ cell cancer	6.58e-05	0.0013	CbGeAlD
Tamoxifen—ABCB1—retina—germ cell cancer	6.54e-05	0.00129	CbGeAlD
Tamoxifen—DHCR7—Metabolism—SLC2A3—germ cell cancer	6.41e-05	0.00166	CbGpPWpGaD
Tamoxifen—Nausea—Ifosfamide—germ cell cancer	6.41e-05	0.000823	CcSEcCtD
Tamoxifen—Diarrhoea—Cisplatin—germ cell cancer	6.36e-05	0.000817	CcSEcCtD
Tamoxifen—CYP2E1—testis—germ cell cancer	6.36e-05	0.00126	CbGeAlD
Tamoxifen—Alopecia—Methotrexate—germ cell cancer	6.35e-05	0.000815	CcSEcCtD
Tamoxifen—DHCR7—Metabolism—SLC22A3—germ cell cancer	6.32e-05	0.00163	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—SLC2A3—germ cell cancer	6.29e-05	0.00163	CbGpPWpGaD
Tamoxifen—Hypersensitivity—Etoposide—germ cell cancer	6.28e-05	0.000806	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—germ cell cancer	6.25e-05	0.000803	CcSEcCtD
Tamoxifen—SULT1A1—Metabolism—SLC22A3—germ cell cancer	6.2e-05	0.0016	CbGpPWpGaD
Tamoxifen—Dysgeusia—Methotrexate—germ cell cancer	6.12e-05	0.000787	CcSEcCtD
Tamoxifen—Asthenia—Etoposide—germ cell cancer	6.11e-05	0.000785	CcSEcCtD
Tamoxifen—EBP—Metabolism—SLC2A3—germ cell cancer	6.08e-05	0.00157	CbGpPWpGaD
Tamoxifen—Back pain—Methotrexate—germ cell cancer	6.05e-05	0.000777	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—germ cell cancer	6.03e-05	0.000774	CcSEcCtD
Tamoxifen—ABCB1—telencephalon—germ cell cancer	6.02e-05	0.00119	CbGeAlD
Tamoxifen—EBP—Metabolism—SLC22A3—germ cell cancer	5.99e-05	0.00155	CbGpPWpGaD
Tamoxifen—Vomiting—Cisplatin—germ cell cancer	5.91e-05	0.000759	CcSEcCtD
Tamoxifen—CYP2E1—cerebellum—germ cell cancer	5.87e-05	0.00116	CbGeAlD
Tamoxifen—Rash—Cisplatin—germ cell cancer	5.86e-05	0.000753	CcSEcCtD
Tamoxifen—Dermatitis—Cisplatin—germ cell cancer	5.86e-05	0.000752	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—germ cell cancer	5.83e-05	0.000749	CcSEcCtD
Tamoxifen—ESR2—Gene Expression—DNMT3L—germ cell cancer	5.83e-05	0.00151	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FGF4—germ cell cancer	5.78e-05	0.0015	CbGpPWpGaD
Tamoxifen—Anaemia—Methotrexate—germ cell cancer	5.78e-05	0.000742	CcSEcCtD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.73e-05	0.00148	CbGpPWpGaD
Tamoxifen—ABCB1—decidua—germ cell cancer	5.71e-05	0.00113	CbGeAlD
Tamoxifen—CYP2D6—female gonad—germ cell cancer	5.68e-05	0.00112	CbGeAlD
Tamoxifen—CYP2C8—brain—germ cell cancer	5.67e-05	0.00112	CbGeAlD
Tamoxifen—Dizziness—Etoposide—germ cell cancer	5.63e-05	0.000724	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—germ cell cancer	5.6e-05	0.000719	CcSEcCtD
Tamoxifen—Nausea—Cisplatin—germ cell cancer	5.52e-05	0.00071	CcSEcCtD
Tamoxifen—ABCG2—brain—germ cell cancer	5.51e-05	0.00109	CbGeAlD
Tamoxifen—Cough—Methotrexate—germ cell cancer	5.46e-05	0.000701	CcSEcCtD
Tamoxifen—ESR2—Gene Expression—RARS—germ cell cancer	5.42e-05	0.0014	CbGpPWpGaD
Tamoxifen—Vomiting—Etoposide—germ cell cancer	5.42e-05	0.000696	CcSEcCtD
Tamoxifen—Rash—Etoposide—germ cell cancer	5.37e-05	0.00069	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—germ cell cancer	5.37e-05	0.000689	CcSEcCtD
Tamoxifen—CYP3A4—endocrine gland—germ cell cancer	5.36e-05	0.00106	CbGeAlD
Tamoxifen—Headache—Etoposide—germ cell cancer	5.34e-05	0.000686	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—germ cell cancer	5.32e-05	0.000684	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—germ cell cancer	5.32e-05	0.000684	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—germ cell cancer	5.32e-05	0.000684	CcSEcCtD
Tamoxifen—ABCG2—lymph node—germ cell cancer	5.32e-05	0.00105	CbGeAlD
Tamoxifen—CYP2D6—endocrine gland—germ cell cancer	5.28e-05	0.00104	CbGeAlD
Tamoxifen—Discomfort—Methotrexate—germ cell cancer	5.26e-05	0.000676	CcSEcCtD
Tamoxifen—CYP1A1—brain—germ cell cancer	5.23e-05	0.00103	CbGeAlD
Tamoxifen—FMO1—Metabolism—SLC2A3—germ cell cancer	5.23e-05	0.00135	CbGpPWpGaD
Tamoxifen—CYP2D6—head—germ cell cancer	5.21e-05	0.00103	CbGeAlD
Tamoxifen—FMO1—Metabolism—SLC22A3—germ cell cancer	5.15e-05	0.00133	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CRABP1—germ cell cancer	5.15e-05	0.00133	CbGpPWpGaD
Tamoxifen—CYP2B6—brain—germ cell cancer	5.08e-05	0.00101	CbGeAlD
Tamoxifen—Infection—Methotrexate—germ cell cancer	5.07e-05	0.000651	CcSEcCtD
Tamoxifen—Nausea—Etoposide—germ cell cancer	5.06e-05	0.00065	CcSEcCtD
Tamoxifen—SULT1A1—Metabolism—CRABP1—germ cell cancer	5.05e-05	0.00131	CbGpPWpGaD
Tamoxifen—CYP1A1—lymph node—germ cell cancer	5.05e-05	0.001	CbGeAlD
Tamoxifen—CYP2D6—testis—germ cell cancer	5.03e-05	0.000996	CbGeAlD
Tamoxifen—ABCB1—gonad—germ cell cancer	5.02e-05	0.000994	CbGeAlD
Tamoxifen—Thrombocytopenia—Methotrexate—germ cell cancer	5e-05	0.000642	CcSEcCtD
Tamoxifen—ABCB1—uterus—germ cell cancer	4.99e-05	0.000987	CbGeAlD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.99e-05	0.00129	CbGpPWpGaD
Tamoxifen—ESR1—FOXM1 transcription factor network—MYC—germ cell cancer	4.99e-05	0.00129	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.98e-05	0.00129	CbGpPWpGaD
Tamoxifen—Hyperhidrosis—Methotrexate—germ cell cancer	4.93e-05	0.000634	CcSEcCtD
Tamoxifen—ABCB1—pituitary gland—germ cell cancer	4.9e-05	0.00097	CbGeAlD
Tamoxifen—ESR1—LKB1 signaling events—MYC—germ cell cancer	4.9e-05	0.00127	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CRABP1—germ cell cancer	4.88e-05	0.00126	CbGpPWpGaD
Tamoxifen—Anorexia—Methotrexate—germ cell cancer	4.87e-05	0.000625	CcSEcCtD
Tamoxifen—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	4.86e-05	0.00126	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—SLC2A3—germ cell cancer	4.86e-05	0.00126	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—SLC22A3—germ cell cancer	4.79e-05	0.00124	CbGpPWpGaD
Tamoxifen—CYP2E1—brain—germ cell cancer	4.77e-05	0.000944	CbGeAlD
Tamoxifen—ESR1—Signaling by ERBB4—KITLG—germ cell cancer	4.75e-05	0.00123	CbGpPWpGaD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	4.74e-05	0.00123	CbGpPWpGaD
Tamoxifen—ABCB1—medulla oblongata—germ cell cancer	4.73e-05	0.000936	CbGeAlD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	4.68e-05	0.00121	CbGpPWpGaD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—germ cell cancer	4.65e-05	0.000597	CcSEcCtD
Tamoxifen—CYP2D6—cerebellum—germ cell cancer	4.65e-05	0.00092	CbGeAlD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.64e-05	0.0012	CbGpPWpGaD
Tamoxifen—Insomnia—Methotrexate—germ cell cancer	4.62e-05	0.000593	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—germ cell cancer	4.58e-05	0.000589	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—germ cell cancer	4.55e-05	0.000584	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—germ cell cancer	4.49e-05	0.000577	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—germ cell cancer	4.44e-05	0.00057	CcSEcCtD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—TP53—germ cell cancer	4.42e-05	0.00114	CbGpPWpGaD
Tamoxifen—Gastrointestinal disorder—Methotrexate—germ cell cancer	4.41e-05	0.000566	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—germ cell cancer	4.4e-05	0.000565	CcSEcCtD
Tamoxifen—ABCB1—adrenal gland—germ cell cancer	4.38e-05	0.000866	CbGeAlD
Tamoxifen—Pain—Methotrexate—germ cell cancer	4.36e-05	0.000561	CcSEcCtD
Tamoxifen—ABCB1—midbrain—germ cell cancer	4.32e-05	0.000855	CbGeAlD
Tamoxifen—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	4.32e-05	0.00112	CbGpPWpGaD
Tamoxifen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	4.24e-05	0.0011	CbGpPWpGaD
Tamoxifen—ABCB1—bone marrow—germ cell cancer	4.24e-05	0.000838	CbGeAlD
Tamoxifen—ABCB1—spinal cord—germ cell cancer	4.22e-05	0.000834	CbGeAlD
Tamoxifen—FMO1—Metabolism—CRABP1—germ cell cancer	4.2e-05	0.00109	CbGpPWpGaD
Tamoxifen—Gastrointestinal pain—Methotrexate—germ cell cancer	4.17e-05	0.000536	CcSEcCtD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.16e-05	0.00108	CbGpPWpGaD
Tamoxifen—ABCB1—female gonad—germ cell cancer	4.08e-05	0.000808	CbGeAlD
Tamoxifen—Urticaria—Methotrexate—germ cell cancer	4.05e-05	0.000521	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—germ cell cancer	4.03e-05	0.000518	CcSEcCtD
Tamoxifen—ESR1—LKB1 signaling events—TP53—germ cell cancer	4.02e-05	0.00104	CbGpPWpGaD
Tamoxifen—ESR1—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	4e-05	0.00103	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.92e-05	0.00101	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CRABP1—germ cell cancer	3.9e-05	0.00101	CbGpPWpGaD
Tamoxifen—Phenoxybenzamine—SLC22A3—germ cell cancer	3.81e-05	1	CrCbGaD
Tamoxifen—ABCB1—endocrine gland—germ cell cancer	3.8e-05	0.000751	CbGeAlD
Tamoxifen—CYP2D6—brain—germ cell cancer	3.78e-05	0.000747	CbGeAlD
Tamoxifen—Hypersensitivity—Methotrexate—germ cell cancer	3.76e-05	0.000483	CcSEcCtD
Tamoxifen—ABCB1—head—germ cell cancer	3.75e-05	0.000742	CbGeAlD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.75e-05	0.000969	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—SLC2A3—germ cell cancer	3.74e-05	0.000967	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.69e-05	0.000955	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—SLC22A3—germ cell cancer	3.68e-05	0.000952	CbGpPWpGaD
Tamoxifen—Asthenia—Methotrexate—germ cell cancer	3.66e-05	0.00047	CcSEcCtD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.64e-05	0.000943	CbGpPWpGaD
Tamoxifen—ABCB1—testis—germ cell cancer	3.62e-05	0.000716	CbGeAlD
Tamoxifen—Pruritus—Methotrexate—germ cell cancer	3.61e-05	0.000464	CcSEcCtD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	3.56e-05	0.000922	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FGFR3—germ cell cancer	3.53e-05	0.000913	CbGpPWpGaD
Tamoxifen—Diarrhoea—Methotrexate—germ cell cancer	3.49e-05	0.000448	CcSEcCtD
Tamoxifen—ESR1—Regulation of Telomerase—MYC—germ cell cancer	3.39e-05	0.000878	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—NR0B1—germ cell cancer	3.39e-05	0.000877	CbGpPWpGaD
Tamoxifen—Dizziness—Methotrexate—germ cell cancer	3.38e-05	0.000433	CcSEcCtD
Tamoxifen—ABCB1—cerebellum—germ cell cancer	3.34e-05	0.000662	CbGeAlD
Tamoxifen—ESR1—AP-1 transcription factor network—MYC—germ cell cancer	3.32e-05	0.000858	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.26e-05	0.000843	CbGpPWpGaD
Tamoxifen—Vomiting—Methotrexate—germ cell cancer	3.25e-05	0.000417	CcSEcCtD
Tamoxifen—ESR1—Signaling by ERBB4—KIT—germ cell cancer	3.24e-05	0.000839	CbGpPWpGaD
Tamoxifen—Rash—Methotrexate—germ cell cancer	3.22e-05	0.000413	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—germ cell cancer	3.22e-05	0.000413	CcSEcCtD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.21e-05	0.00083	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—H2AFZ—germ cell cancer	3.21e-05	0.000829	CbGpPWpGaD
Tamoxifen—Headache—Methotrexate—germ cell cancer	3.2e-05	0.000411	CcSEcCtD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.14e-05	0.000813	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—SLC2A3—germ cell cancer	3.13e-05	0.00081	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—SLC22A3—germ cell cancer	3.08e-05	0.000798	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	3.07e-05	0.000795	CbGpPWpGaD
Tamoxifen—Nausea—Methotrexate—germ cell cancer	3.03e-05	0.000389	CcSEcCtD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.02e-05	0.000783	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CRABP1—germ cell cancer	3e-05	0.000776	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	2.95e-05	0.000763	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.95e-05	0.000762	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—DNMT3L—germ cell cancer	2.94e-05	0.00076	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—RARS—germ cell cancer	2.73e-05	0.000707	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—germ cell cancer	2.72e-05	0.000705	CbGpPWpGaD
Tamoxifen—ABCB1—brain—germ cell cancer	2.72e-05	0.000537	CbGeAlD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.69e-05	0.000697	CbGpPWpGaD
Tamoxifen—ABCB1—lymph node—germ cell cancer	2.63e-05	0.000519	CbGeAlD
Tamoxifen—UGT1A4—Metabolism—CRABP1—germ cell cancer	2.51e-05	0.000651	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—HRAS—germ cell cancer	2.46e-05	0.000638	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.42e-05	0.000626	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	2.41e-05	0.000625	CbGpPWpGaD
Tamoxifen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	2.33e-05	0.000604	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SLC2A3—germ cell cancer	2.31e-05	0.000597	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—MYC—germ cell cancer	2.3e-05	0.000595	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SLC22A3—germ cell cancer	2.27e-05	0.000588	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—H2AFZ—germ cell cancer	2.04e-05	0.000528	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	2e-05	0.000518	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	1.96e-05	0.000507	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.86e-05	0.000482	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CRABP1—germ cell cancer	1.85e-05	0.00048	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	1.79e-05	0.000464	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.76e-05	0.000456	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SLC2A3—germ cell cancer	1.74e-05	0.000451	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.74e-05	0.000449	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.73e-05	0.000447	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SLC22A3—germ cell cancer	1.72e-05	0.000444	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.71e-05	0.000442	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SLC2A3—germ cell cancer	1.68e-05	0.000434	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SLC22A3—germ cell cancer	1.65e-05	0.000428	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	1.64e-05	0.000426	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.54e-05	0.000398	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.53e-05	0.000395	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.52e-05	0.000394	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SLC2A3—germ cell cancer	1.51e-05	0.000391	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.5e-05	0.000389	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.5e-05	0.000389	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SLC22A3—germ cell cancer	1.49e-05	0.000386	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.49e-05	0.000384	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	1.47e-05	0.000381	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—MYC—germ cell cancer	1.46e-05	0.000379	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—HRAS—germ cell cancer	1.4e-05	0.000362	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CRABP1—germ cell cancer	1.4e-05	0.000362	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.39e-05	0.00036	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SLC2A3—germ cell cancer	1.39e-05	0.000359	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SLC22A3—germ cell cancer	1.37e-05	0.000353	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CRABP1—germ cell cancer	1.35e-05	0.000348	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CRABP1—germ cell cancer	1.23e-05	0.000317	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.22e-05	0.000316	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CRABP1—germ cell cancer	1.21e-05	0.000314	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.19e-05	0.000307	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC2A3—germ cell cancer	1.12e-05	0.000289	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CRABP1—germ cell cancer	1.11e-05	0.000288	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MYC—germ cell cancer	1.11e-05	0.000286	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC22A3—germ cell cancer	1.1e-05	0.000285	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC2A3—germ cell cancer	1.1e-05	0.000283	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC2A3—germ cell cancer	1.09e-05	0.000283	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC22A3—germ cell cancer	1.08e-05	0.000279	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC22A3—germ cell cancer	1.08e-05	0.000279	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC2A3—germ cell cancer	1.03e-05	0.000267	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—H2AFZ—germ cell cancer	1.03e-05	0.000266	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC22A3—germ cell cancer	1.02e-05	0.000263	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC2A3—germ cell cancer	9.47e-06	0.000245	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC22A3—germ cell cancer	9.33e-06	0.000241	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CRABP1—germ cell cancer	8.98e-06	0.000232	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CRABP1—germ cell cancer	8.8e-06	0.000228	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CRABP1—germ cell cancer	8.78e-06	0.000227	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—OXT—germ cell cancer	8.77e-06	0.000227	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC2A3—germ cell cancer	8.45e-06	0.000219	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC22A3—germ cell cancer	8.33e-06	0.000215	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CRABP1—germ cell cancer	8.3e-06	0.000215	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC2A3—germ cell cancer	8.25e-06	0.000213	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC22A3—germ cell cancer	8.13e-06	0.00021	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	8.12e-06	0.00021	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.86e-06	0.000203	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC2A3—germ cell cancer	7.78e-06	0.000201	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC2A3—germ cell cancer	7.71e-06	0.000199	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC22A3—germ cell cancer	7.66e-06	0.000198	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CRABP1—germ cell cancer	7.61e-06	0.000197	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC22A3—germ cell cancer	7.59e-06	0.000196	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF4—germ cell cancer	7.49e-06	0.000194	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MYC—germ cell cancer	7.38e-06	0.000191	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MYC—germ cell cancer	7.05e-06	0.000182	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CRABP1—germ cell cancer	6.79e-06	0.000176	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—H2AFZ—germ cell cancer	6.69e-06	0.000173	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CRABP1—germ cell cancer	6.63e-06	0.000171	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC2A3—germ cell cancer	6.59e-06	0.00017	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC22A3—germ cell cancer	6.49e-06	0.000168	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	6.46e-06	0.000167	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CRABP1—germ cell cancer	6.24e-06	0.000162	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CRABP1—germ cell cancer	6.19e-06	0.00016	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KITLG—germ cell cancer	6.15e-06	0.000159	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AVP—germ cell cancer	6.01e-06	0.000156	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CRABP1—germ cell cancer	5.29e-06	0.000137	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A3—germ cell cancer	5.08e-06	0.000132	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC22A3—germ cell cancer	5.01e-06	0.00013	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGFR3—germ cell cancer	4.57e-06	0.000118	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KIT—germ cell cancer	4.2e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CRABP1—germ cell cancer	4.08e-06	0.000106	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—germ cell cancer	3.55e-06	9.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—germ cell cancer	2.31e-06	5.98e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—germ cell cancer	1.9e-06	4.91e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—germ cell cancer	1.81e-06	4.69e-05	CbGpPWpGaD
